Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can hormone pills cure your jet lag? new study tests hydrocortisone and melatonin

NCT ID NCT00097474

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 25, 2026 · Updated 14 times

Summary

This study tested whether taking hydrocortisone (a cortisol-like hormone), melatonin, or both could reduce jet lag symptoms after long eastward flights. Fifty-seven healthy adults aged 18-65 who flew across 6-8 time zones took the pills for 4 days after arrival and reported their symptoms. The goal was to see if these hormones help reset the body's internal clock and ease jet lag.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hydrocortisone and Melatonin
What this could lead to
If it works, this could point toward a simple, short-term treatment to reduce jet lag symptoms after long flights.
What could go wrong
This is a small, completed Phase 2 trial with only 57 participants, so results may not apply to everyone. The effects may be modest or no better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

57 people

The number who actually took part.

Started

Dec 2004

Finished

Nov 2007

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: * Age greater than or equal to 18, but less than or equal to 65, male or female. * Normal physical exam and laboratory results. * Negative urinary pregnancy test 1 week prior to travel (pre-menopausal women). * Planned eastward flight crossing 6-8 time zones between 30n and 50n latitudes. * A minimum stay of 7 - 10 days abroad. * Willingness and anticipated ability to comply with study procedures, including sleep and wake hours, saliva collection and questionnaire completion. * Written informed consent. EXCLUSION CRITERIA: * BMI less than or equal to 20 or greater than or equal to 30 kg/m. * Current psychiatric or seizure disorder. * Current sleep disorder as assessed by presence of sleep apnea, daytime napping of more than 20 minutes, chronic fatigue. * History of Cushing's syndrome. * Serious chronic medical condition. * Current drug or alcohol abuse. * SGOT or SGPT greater than three-fold normal. * Current pregnancy or lactation. * Current use of CPAP. * Chronic use of beta-blockers (which inhibit melatonin secretion), anti-epileptic agents, anticoagulants, fluvoxamine, nifedipine or soporific or sleep-inducing agents (including benzodiazepines, melatonin), or glucocorticoids. * Fasting blood glucose greater than 110 mg/dL or known diabetes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Jet lag are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.